Acute respiratory distress syndrome (ARDS) is a common clinical syndrome of acute
respiratory failure as a result of diffuse lung inflammation and oedema. ARDS can be …

Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

Acute respiratory distress syndrome (ARDS) is a severe organ failure occurring mainly in
critically ill patients as a result of different types of insults such as sepsis, trauma or …

Acute respiratory distress syndrome (ARDS) is a common and life-threatening cause of
respiratory failure. Despite decades of research, there are no effective pharmacologic …

Whilst the presence of 2 subphenotypes among the heterogenous Acute Respiratory
Distress Syndrome (ARDS) population is becoming clinically accepted, subphenotype …

The roles of thioredoxin-interacting protein (TXNIP) and receptor for advanced glycation end-
products (RAGE)-dependent mechanisms of NOD-like receptor family, pyrin domain …

At present, the management of patients with acute respiratory distress syndrome (ARDS)
largely focuses on ventilator settings to limit intrathoracic pressures by using low tidal …

Background Preclinical studies in acute respiratory distress syndrome (ARDS) have
suggested that inhaled sevoflurane may have lung-protective effects and clinical trials are …

Background: There is not much evidence on the prognostic utility of different biological
markers in patients with severe COVID-19 living at high altitude. The objective of this study …

Abstract Background In the United States (US) and in Europe, cystic fibrosis (CF) qualifies as
a rare disease, thus positioning the field to benefit from regulatory incentives provided by …